You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTY Award Disclosure
Nelsen Robert · SEC Form 4 · Filed Oct 19, 2026
Award
Calculated transaction value
$0
Nelsen Robert Director / Ten Percent Owner
CTY
Transaction date
Oct 15, 2026
Public filing date
Oct 19, 2026
Filing lag
Filed 4 days later
CTY daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 22,649 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001104659-26-116965
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$3.06M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | $0 |
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | Not reported |
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | $0 |
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | $0 |
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | Not reported |
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | Not reported |
| City Therapeutics, Inc. CTY | Buy | Oct 19, 2026 | $3.06M |
| City Therapeutics, Inc. CTY Current | Award | Oct 15, 2026 | $0 |